AstraZeneca Pharma down 15% on stake dilution news

AstraZeneca Pharma fell nearly 15 percent to touch a 52-week low of Rs 711.20 in early trade on Wednesday after the company said its promoter AB Sweden decided to reduce stake in the company.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset
moneycontrol.com

Home » News » Business

Mar 06, 2013, 07.51 PM | Source: Moneycontrol.com

AstraZeneca Pharma down 15% on stake dilution news

AstraZeneca Pharma fell nearly 15 percent to touch a 52-week low of Rs 711.20 in early trade on Wednesday after the company said its promoter AB Sweden decided to reduce stake in the company.

Like this story, share it with millions of investors on M3

AstraZeneca Pharma down 15% on stake dilution news

AstraZeneca Pharma fell nearly 15 percent to touch a 52-week low of Rs 711.20 in early trade on Wednesday after the company said its promoter AB Sweden decided to reduce stake in the company.

Post Your Comments

Share Cancel

Ushang Sheth (more)

Research Analyst, CNBC-TV18 |

AstraZeneca Pharma fell nearly 15 percent to touch a 52-week low of Rs 711.20 in early trade on Wednesday after the company said its promoter AB Sweden decided to reduce stake in the company.

The stock recovered in late afternoon trade and gained more than 9 percent to Rs 910.20 but it could not sustain gains for long and turned lower again in last couple of hours of trade.

The dilution of shareholding is for complying minimum public shareholding norms set by SEBI.

Parent company's current shareholding in company stands at 89.99 percent.

At 15:05 hours IST, shares fell 7.26 percent to Rs 773.20 amid hefty volumes on Bombay Stock Exchange.

Trading volumes increased 53 times to 4,59,032 equity shares as against five-day average of 8,684 shares

In the previous trading session too, the stock dropped 3.38 percent to Rs 833.75.

AstraZeneca stock price

On May 25, 2016, AstraZeneca Pharma closed at Rs 1096.35, up Rs 2.80, or 0.26 percent. The 52-week high of the share was Rs 1348.00 and the 52-week low was Rs 850.00.


The company's trailing 12-month (TTM) EPS was at Rs 17.13 per share as per the quarter ended March 2016. The stock's price-to-earnings (P/E) ratio was 64. The latest book value of the company is Rs 60.30 per share. At current value, the price-to-book value of the company is 18.18.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
AstraZeneca Pharma down 15% on stake dilution news

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login